Alphaform

Alphaform EV/EBITDA

The EV/EBITDA (Enterprise Value to EBITDA) of Alphaform (AFRMF) as of Nov 6, 2026 is 0.16.

EV/EBITDA

0.16

Last updated:

EV/EBITDA (Enterprise Value to EBITDA) of Alphaform is 2014 0.16 . EV/EBITDA (Enterprise Value to EBITDA) of Alphaform was 2013 - . It decreases by % lower compared to the previous year.

The Alphaform EV/EBITDA history

The Alphaform EV/EBITDA history
YEAREV/EBITDAYoY
0.16—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Alphaform Stock analysis

What does Alphaform do? Alphaform AG generates revenue through industrial development services and production using innovative 3D printing technologies. The company specializes in laser sintering and stereo-lithography, producing prototype parts and models from resin and plastic powder. Clients from the automobile and aerospace industries purchase these services, including modeling, finishing, coating, and metal coating. Subsidiaries like Alphaform-Claho GmbH provide additional services such as tool making and CNC milling, while Medi-Met Precision Casting and Implants Technology GmbH focuses on manufacturing semi-finished medical implants like knee and hip implants. Alphaform-Claho GmbH serves clients requiring precision tool making and CNC milling for various parts, complementing Alphaform AG's core 3D printing offerings. Medi-Met Precision Casting and Implants Technology GmbH targets the medical sector with semi-finished implants, directly serving healthcare providers and medical device manufacturers. The company’s product portfolio spans industrial prototyping, precision manufacturing, and medical implant components, all delivered through its subsidiaries and core services. The automobile and aerospace industries are key clients for Alphaform AG's 3D printed parts and related services. Alphaform-Claho GmbH supports these sectors with tool making and CNC milling capabilities, enhancing the production process for complex components. Medi-Met Precision Casting and Implants Technology GmbH caters to the medical industry, supplying semi-finished implants that require high precision and specialized manufacturing techniques. Alphaform is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Alphaform stock

EV/EBITDA (Enterprise Value to EBITDA) of Alphaform is 0.16 in 2014.

On Eulerpool you can find the complete historical development of EV/EBITDA (Enterprise Value to EBITDA) Alphaform since 2006 – with annual values, charts, and detailed analysis.

The EV/EBITDA ratio is a widely used valuation metric that compares a company's enterprise value to its EBITDA. It normalizes for differences in capital structure, taxation, and depreciation policies.

To evaluate EV/EBITDA (Enterprise Value to EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBITDA (Enterprise Value to EBITDA).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBITDA (Enterprise Value to EBITDA)'s Alphaform with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Alphaform

All Key Metrics — Alphaform